Oxycodone Hydrochloride

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

30 Suppliers, 13 USDMF, 11 CEP/COS, 1 JDMF, 1 EU WC, 7 KDMF, 17 NDC API, 17 Listed Suppliers

PRICE INFORMATION

API Reference Price, API Imports, FDF Imports

INTERMEDIATES

2 Suppliers

2 Suppliers

DOSSIERs // Finished Dosage Forms

737 Dossiers, 289 FDA Orange Book, 289 Europe, 51 Canada, 47 Australia, 17 South Africa, 44 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - 5MG, SOLUTION;ORAL - 100MG/5ML, SOLUTION;ORAL - 5MG/5ML, SOLUTION;ORAL - 5MG/5ML, TABLET;ORAL - 5MG, TABLET;ORAL - 7.5MG, TABLET, EXTENDED RELEASE;ORAL - 325MG;7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 13.5MG, CAPSULE, EXTENDED RELEASE;ORAL - 18MG, CAPSULE, EXTENDED RELEASE;ORAL - 27MG, CAPSULE, EXTENDED RELEASE;ORAL - 36MG, CAPSULE, EXTENDED RELEASE;ORAL - 9MG, TABLET, EXTENDED RELEASE;ORAL - 10MG, TABLET, EXTENDED RELEASE;ORAL - 15MG, TABLET, EXTENDED RELEASE;ORAL - 20MG, TABLET, EXTENDED RELEASE;ORAL - 30MG, TABLET, EXTENDED RELEASE;ORAL - 40MG, TABLET, EXTENDED RELEASE;ORAL - 60MG, TABLET, EXTENDED RELEASE;ORAL - 80MG, TABLET;ORAL - 325MG;5MG

RELATED EXCIPIENT COMPANIES

Suppliers, 40 Roquette, 39 Kerry, 38 BASF, 22 Corel Pharma Chem, 22 SPI Pharma, 19 Microlex e.U, 14 Actylis, 14 Seppic, 14 Gangwal Healthcare, 13 Gangwal Chemicals, 12 Sigachi Industries, 12 Ideal Cures Pvt Ltd, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Nanjing Well Pharmaceutical, 7 Rochem International Inc, 7 DKSH, 7 Boai NKY Pharmaceuticals Ltd, 7 DFE Pharma, 6 Lonza Capsugel, 5 Ingredion Pharma Solutions, 5 Vasa Pharmachem, 4 Kima Chemical, 4 ACG Worldwide, 4 Pharmatrans-Sanaq, 4 Evonik, 4 Prachin Chemical, 3 Shijiazhuang Huaxu Pharmaceutical, 3 Pfanstiehl, 3 Ulanqab Kema New Material, 3 The Dow Chemical Company, 2 Qualicaps, 2 Pharm-RX Chemical, 2 Alcedo Pharmachem, 2 Nanjing Bold Chemical, 2 Seqens, 2 Finar, 2 Nomisma Healthcare, 2 Zhejiang Huakang Pharmaceutical, 2 Jai Radhe Sales, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Clariant, 1 Aeon Procare, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Bioplus Life Sciences, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

98 Fillers, Diluents & Binders, 75 Coating Systems & Additives, 57 Controlled & Modified Release, 49 Direct Compression, 44 Disintegrants & Superdisintegrants, 38 Taste Masking, 35 Thickeners and Stabilizers, 35 Granulation, 32 Solubilizers, 27 Film Formers & Plasticizers, 26 Parenteral, 25 Lubricants & Glidants, 22 Chewable & Orodispersible Aids, 20 Topical, 19 Co-Processed Excipients, 9 Empty Capsules, 9 API Stability Enhancers, 6 Emulsifying Agents, 5 Rheology Modifiers, 4 Vegetarian Capsules, 3 Surfactant & Foaming Agents, 2 Coloring Agents, 1 Soft Gelatin

GLOBAL SALES INFORMATION

37 US Medicaid Prescriptions, 213 Finished Drug Prices

MARKET PLACE

7 APIs, 9 DOSSIERS // FDF

PATENTS

209 US Patents, 4 US Exclusivities, 55 Health Canada Patents

ANALYTICAL SOLUTION(s)

2 EDQM Standards, 5 USP Standards, 7 Other Ref. Standards

DIGITAL CONTENT

5 Data Compilation & Company Tracker #PharmaFlow, 289 News

Annual Sales of Oxycodone Hydrochloride reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Oxycodone Hydrochloride

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

30 Suppliers

13 USDMF

11 CEP/COS

1 JDMF

1 EU WC

7 KDMF

17 NDC API

17 Listed Suppliers

PRICE INFORMATION

API Reference Price

API Imports

FDF Imports

INTERMEDIATES

2 Suppliers

DOSSIERs // Finished Dosage Forms

737 Dossiers

289 FDA Orange Book

289 Europe

51 Canada

47 Australia

17 South Africa

44 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - 5MG

SOLUTION;ORAL - 100MG/5ML

SOLUTION;ORAL - 5MG/5ML

SOLUTION;ORAL - 5MG/5ML

TABLET;ORAL - 5MG

TABLET;ORAL - 7.5MG

TABLET, EXTENDED RELEASE;ORAL - 325MG;7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 13.5MG

CAPSULE, EXTENDED RELEASE;ORAL - 18MG

CAPSULE, EXTENDED RELEASE;ORAL - 27MG

CAPSULE, EXTENDED RELEASE;ORAL - 36MG

CAPSULE, EXTENDED RELEASE;ORAL - 9MG

TABLET, EXTENDED RELEASE;ORAL - 10MG

TABLET, EXTENDED RELEASE;ORAL - 15MG

TABLET, EXTENDED RELEASE;ORAL - 20MG

TABLET, EXTENDED RELEASE;ORAL - 30MG

TABLET, EXTENDED RELEASE;ORAL - 40MG

TABLET, EXTENDED RELEASE;ORAL - 60MG

TABLET, EXTENDED RELEASE;ORAL - 80MG

TABLET;ORAL - 325MG;5MG

RELATED EXCIPIENT COMPANIES

Suppliers

40 Roquette

39 Kerry

38 BASF

22 Corel Pharma Chem

22 SPI Pharma

19 Microlex e.U

14 Actylis

14 Seppic

14 Gangwal Healthcare

13 Gangwal Chemicals

12 Sigachi Industries

12 Ideal Cures Pvt Ltd

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

8 Nanjing Well Pharmaceutical

7 Rochem International Inc

7 DKSH

7 Boai NKY Pharmaceuticals Ltd

7 DFE Pharma

6 Lonza Capsugel

5 Ingredion Pharma Solutions

5 Vasa Pharmachem

4 Kima Chemical

4 ACG Worldwide

4 Pharmatrans-Sanaq

4 Evonik

4 Prachin Chemical

3 Shijiazhuang Huaxu Pharmaceutical

3 Pfanstiehl

3 Ulanqab Kema New Material

TABLET, EXTENDED RELEASE;ORAL - 325MG;7.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons